Where to inject Ozempic, Wegovy, Mounjaro and Zepbound, and how to rotate sites

Photo: Haberdoedas / Unsplash
All four weekly GLP-1 labels name the same three areas: the abdomen, the thigh and the upper arm. They also agree on one habit: use a different spot with every dose. The labels don't name a "best" area.
The three areas
- Ozempic and Wegovy: inject under the skin of the abdomen, thigh or upper arm. Their instructions for use add: in the stomach area, keep at least 2 inches (5 cm) from the belly button.
- Mounjaro and Zepbound: the abdomen or thigh, or another person injects in the back of the upper arm.
The NHS puts it as the fatty areas of your thigh, tummy or upper arm (for tirzepatide: the back of your upper arm).
Is one area better?
None of the four labels names a preferred area. The Wegovy label says that the time of day and the injection site "can be changed without the need for a dosage modification." If one area is easier or more comfortable for you, ask your prescriber, pharmacist or nurse; the Ozempic instructions note that your healthcare provider can help you choose the site that is best for you.
Rotating sites
This is the one thing every source repeats:
- Ozempic: use a different injection site each week when injecting in the same body region; the Medication Guide says to change (rotate) your injection site with each injection and not to use the same site each time.
- Wegovy, Mounjaro and Zepbound: "Rotate injection sites with each dose."
- NHS: change the place you inject each week; you can use the same area but not the exact same spot.
The labels don't prescribe a pattern. One simple way to keep track, as an example only: move around a fixed order, such as left abdomen, right abdomen, left thigh, right thigh, and write down where each dose went. The record matters more than the order: it answers "where did I inject last week?" without guessing.

If you also inject insulin
The Ozempic and Mounjaro labels say: give them as separate injections and never mix them. You can inject both in the same body region, but not right next to each other. The NHS says to use a different place for each.
Injection site reactions
Redness, itching, bruising or discomfort where you injected are listed in every label. How often they were reported differs:
- Ozempic: reported in 0.2% of people on Ozempic in the placebo-controlled trials (for example discomfort or redness).
- Wegovy: 1.4% on Wegovy and 1% on placebo, including itching, redness, inflammation, hardening and irritation.
- Mounjaro: 3.2% on Mounjaro and 0.4% on placebo.
- Zepbound: 6%, 8% and 8% on 5, 10 and 15 mg, and 2% on placebo, including bruising, redness, itching, pain and rash.
The NHS lists "itchy or red skin where you inject" among the common side effects of tirzepatide. Get medical help right away if you have signs of a serious allergic reaction, such as swelling of your face, lips, tongue or throat, or problems breathing or swallowing; the Ozempic Medication Guide also lists severe rash or itching, fainting or feeling dizzy, and a very rapid heartbeat.
Keeping the pen between doses
Storage is different for each pen, and it is printed in each label (section 16) and in the leaflet in your pack. Before first use, all of the pens below are kept in the fridge at 36°F to 46°F (2°C to 8°C). Out of the fridge, the US labels say:
| Pen | Out of the fridge |
|---|---|
| Ozempic pen | after first use: 56 days at 59°F to 86°F (15°C to 30°C), or in the fridge |
| Wegovy FlexTouch | after first use: 56 days at 59°F to 86°F (15°C to 30°C), or in the fridge |
| Wegovy single-dose pen | if needed, before the cap is removed: up to 28 days at 46°F to 86°F (8°C to 30°C) |
| Mounjaro / Zepbound single-dose pen | if needed: up to 21 days in total, not above 86°F (30°C) |
| Mounjaro / Zepbound KwikPen | unopened: thrown away after 30 days at room temperature (up to 86°F / 30°C); opened: thrown away after 30 days or 4 weekly doses |
All four labels say: never freeze the pen, don't use it if it has been frozen, and protect it from heat and light. Check the leaflet in your own pack, because pens differ by country and presentation.
This page is general information from the sources below, not medical advice. Follow the instructions for use that come with your pen, and ask your prescriber, pharmacist or nurse to show you how to inject.
- Ozempic (semaglutide) injection: US Prescribing Information, Medication Guide and Instructions for Use, Novo Nordisk, revised 05/2026 (sections 2.1, 6.1 and 16), checked 20 November 2026.
- Wegovy (semaglutide) injection and tablets: US Prescribing Information and Instructions for Use, Novo Nordisk, revised 06/2026 (sections 2.1, 6.1 and 16), checked 20 November 2026.
- Mounjaro (tirzepatide) injection: US Prescribing Information, Eli Lilly, revised 11/2026 (sections 2.2, 6.1 and 16.2), checked 20 November 2026.
- Zepbound (tirzepatide) injection: US Prescribing Information, Eli Lilly, revised 11/2026 (sections 2.4, 6.1 and 16.2), checked 20 November 2026.
- NHS: Semaglutide and NHS: Tirzepatide, checked 20 November 2026.